Candel Therapeutics, Inc.
Candel Therapeutics, Inc. (CADL) — Form 3: Initial insider holdings
About this filing
Candel Therapeutics, Inc. (CADL) filed Form 3 (initial insider holdings) with the SEC on Nov 5, 2026.
Key facts
Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.
More CADL filings
- SC 13G/A
Filed Nov 16, 2026
- 8-K
Filed Nov 12, 2026
- 424B5
Filed Nov 12, 2026
- 10-Q
Filed Nov 12, 2026
- 8-K
Filed Nov 12, 2026
- 4
Filed Nov 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.